Cerebral Therapeutics Names Julie Foster as Chief Operating Officer
Strategic Appointment to Guide Business Operations, Growth and Portfolio Scalability
January 25, 2023 04:05 PM Eastern Standard Time
AURORA, Colo.--(BUSINESS WIRE)--Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment of MedTech industry veteran Julie Foster as Chief Operating Officer. Julie succeeds John Foster who served as Cerebral Therapeutic’s President and COO since 2019, who will move into a business advisor role for the company.
